Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Neutron

Rocket Lab vs. Redwire: 1 Stock Has the Stronger Growth Story for the Next Decade

The SpaceX IPO may have opened a new chapter for space investing. Between Rocket Lab and Redwire, one has the more intriguing long-term growth story.

Barchart

Dear Rocket Lab Stock Fans, Mark Your Calendars for June 22

RKLB will be added to the Nasdaq-100 next week.

Barchart

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Rocket Lab's 18% pullback from its 52-week high appears to reflect normal consolidation rather than any deterioration in business fundamentals.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Despite Positive Developments, Rocket Lab Stock Is a High-Risk Name

Rocket Lab is having trouble with a key rocket.

Barchart

Rocket Lab Stock Is Getting a Major Lift. Investors Are Betting on Its Neutron Launch Later This Year.

Rocket Lab stock is blasting higher as investors bet on the growing demand for Neutron launches, which could position it as a serious competitor in the medium-lift rocket market.

Barchart

Forget the SpaceX IPO: Why Rocket Lab Is the Smarter Space Stock Buy

SpaceX’s IPO could become one of the market’s biggest events, but history suggests mega IPOs often disappoint after launch. Rocket Lab is taking a different path with growing revenue, expanding capabilities, and a proven launch business.

Barchart

The Space Race Just Hit a Bottleneck—Who Benefits?

Blue Origin's grounding of New Glenn after an April 19 mishap tightens an already-constrained launch market, potentially benefiting RKLB, FLY, and LUNR.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Does Rocket Lab's $2 Billion Backlog Offset Dilution Concerns?

Rocket Lab’s $190 million hypersonic contract has propelled its backlog beyond $2 billion, capping a busy week that also included an equity raise announcement. Investors need to balance explosive contract growth against fresh dilution pressures.

Barchart

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

Rocket Lab is stabilizing after an almost 30% pullback from record-highs, with shares holding key support and potentially forming a higher low.

MarketBeat

RKLB Delivers Record Results, But Neutron Delay Weighs on Shares

Rocket Lab (NASDAQ: RKLB) posted record revenue in 2025, expanded margins, and a $1.85 billion backlog, with strong near-term visibility.

MarketBeat

Rocket Lab Earnings Loom as Neutron Timeline Takes Center Stage

Rocket Lab (NASDAQ: RKLB) shares have pulled back nearly 30% from their highs ahead of a pivotal fourth-quarter earnings report.

MarketBeat

Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?

Understand why Rocket Lab pulled back from January highs, what the Neutron testing incident means, and the key levels and catalysts investors are watching.

MarketBeat

Rocket Lab's 'Hungry Hippo' Neutron fairing arrives at spaceport in Virginia

The "hungry hippo" fairing for Rocket Lab's new Neutron launch vehicle has arrived for integration at the company's Virginia Spaceport facilities.

Space

Analysts Remain Steadfast on Rocket Lab After Neutron Test Failure

Shares of Rocket Lab have fallen nearly 20% from recent record highs, following a Neutron test failure and uncertainty about its launch schedule.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Space

Rocket Lab's new Neutron rocket suffers fuel tank rupture during test

Rocket Lab's first Neutron rocket buckled under pressure when its main stage tank ruptured during an overnight test in Wallops, Virginia.

MarketBeat

Rocket Lab Gets a Big Upgrade: Will Upside Follow?

Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.

MarketBeat

5 Stocks Retail Investors Are Betting on for 2026

Retail stock picks have shown real edge in recent years, with previous retail favorites like NVIDIA, Palantir, and Robinhood outperforming the market.

Barchart

As SpaceX Readies for Massive IPO, This Is the Space Stock You Should Be Buying

Amid anticipation for SpaceX’s historic IPO, Rocket Lab shines as an accessible and high-potential space stock with impressive 2025 gains, innovative advancements, and analyst backing for continued growth.

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Why 2026 Could Be Another Breakout Year for Rocket Lab

Rocket Lab has delivered exceptional performance, with shares up nearly 175% year to date, yet remains early in a catalyst-rich growth phase heading into 2026.

Space

Rocket Lab's 'Hungry Hippo' passes final test ahead of 1st reusable Neutron rocket launch

Rocket Lab has signed a contract to launch its new Neutron rocket on a test flight that will advance the U.S. Air Force's point-to-point cargo transportation concept.

MarketBeat

Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift

Analyst sentiment remains strong, with consensus price targets rising steadily to a record $58.17 despite RKLB’s sharp recent pullback.

MarketBeat

Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger

Shares of Rocket Lab are down nearly 40% from recent highs, yet Wall Street remains firmly bullish with several analysts boosting price targets.

Space

Rocket Lab delays debut of powerful, partially reusable Neutron rocket to 2026

Rocket Lab has delayed the first launch of its medium-lift Neutron rocket to 2026, founder and CEO Peter Beck said during a company earnings call on Nov. 10.

MarketBeat

Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay

Rocket Lab posted a strong third quarter with record revenue up 48% year over year, expanding margins, and a $1.1B backlog.

MarketBeat

Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?

Ahead of Q3 earnings, Rocket Lab shares have cooled after a massive rally, dipping roughly 14% from recent highs but remaining up over 150% year-to-date.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.